ATRAPOS THERAPEUTICS
Atrapos Therapeutics develops immunomodulatory therapeutics for the management of diseases originating from overactive immune responses. Atrapos targets STAT6 protein, a key nexus in the dysregulation of immune cell-driven allergic diseases. Other targets upstream of STAT6 that contribute to this dysregulation are currently targeted by FDA-approved therapeutics for the treatment of some of these allergic diseases.
ATRAPOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Houston, Texas, United States
Country:
United States
Status:
Active
Similar Organizations
Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Atlas Regeneration
Atlas Regeneration is developing pioneering bioinformatics solutions for regenerative medicine.
CILcare
CILcare specializes in providing drug solutions for hearing and ear disorders.
DeckTherapeutic
DeckTherapeutics specializes in acute omega-3 fatty acid therapeutics for neuroprotection.
Genpathway, Inc.
Genpathway, Inc. is specializes in providing complete service solutions for the genome-wide analysis of epigenetic events.
Interstate Optical
Interstate Optical specializes in providing high-quality lab services including unique and innovative growth resources.
Medallion Therapeutics
Medallion Therapeutics specializes in drug and biologics delivery solutions.
Sanofi Oncology
Sanofi develops and distributes therapeutic solutions for patient's needs.
StoreMyTumor
StoreMyTumor specializes in tumor preservation, advanced testing, and immune-therapy.
Transposon Therapeutics
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
More informations about "Atrapos Therapeutics"
Team - Atropos Therapeutics
Memorial Sloan-Kettering Cancer Center, Chair and Professor, Department of Molecular Biology; Mouse modeling expert researcher in the field of chromatin, DNA damage, and senescenceSee details»
Atrapos Therapeutics - Crunchbase Company Profile
Atrapos Therapeutics develops immunomodulatory therapeutics for the management of diseases originating from overactive immune responses. โฆSee details»
Atropos Therapeutics 2025 Company Profile: Valuation, โฆ
Atropos Therapeutics General Information Description. Developer of anti-aging drugs designed to treat age-related diseases and cancer. The company's โฆSee details»
Atropos Therapeutics - Crunchbase Company Profile
Organization. Atropos Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Atropos โฆSee details»
Atrapos Therapeutics - VentureRadar
Atrapos Therapeutics is developing targeted immunomodulatory therapeutics for management โฆSee details»
Atropos Therapeutics Inc. - LinkedIn
Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer using its proprietary senescence technology.See details»
Science & Pipeline - Atropos Therapeutics
FATES (First ATRX-based Therapeutics to Elucidate Senescence, patent pending) is a cell-based phenotypic screening platform based on the detection of de novo ATRX foci. It is a rapid and quantitative drug discovery platform. It โฆSee details»
Atrapos Therapeutics LLC - Drug pipelines, Patents, Clinical
Explore Atrapos Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, โฆSee details»
Atropos Therapeutics, Inc. - VentureRadar
Feb 5, 2022 Dorian Therapeutics, Inc. USA Privately Held Dorian Therapeutics is the leading โฆSee details»
Atropos Therapeutics โ Senostimulators/Senosuppressors
Lifespan Research Institute is a 501(c)(3) non-profit organization dedicated to promoting โฆSee details»
Atrapos Therapeutics, LLC :: Texas (US) :: OpenCorporates
Jul 16, 2015 Free and open company data on Texas (US) company Atrapos Therapeutics, โฆSee details»
Atropos Therapeutics, Inc. (Atropos Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
Atropos users can ask questions of over a dozen healthcare organizations' data sets โฆSee details»
Atrapos Therapeutics - Overview, News & Similar companies
Aug 13, 2020 Who is Atrapos Therapeutics. Founded in 2018, Atropos is a biotechnology โฆSee details»
Atrapos Therapeutics, LLC | SBIR.gov
Asthma a chronic disease of the lungs that affects adults and children of all ages has markedly โฆSee details»
NIH Awards Fannin Phase I Grant for Atraposโ Novel Targeted โฆ
Oct 4, 2017 Atrapos was founded in 2015 and is part of Fanninโs growing portfolio of startups โฆSee details»
Longevity senotherapeutics report: Atropos Therapeutics
Jul 15, 2021 Atropos Therapeutics is a biopharmaceutical company that aims to treat age โฆSee details»
Atrapos Therapeutics LLC (Atrapos Therapeutics LLC) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
ไบ่งฃAtrapos Therapeutics LLC (Atrapos Therapeutics LLC)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏ โฆSee details»
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) โฆ
A .gov website belongs to an official government organization in the United States . Secure โฆSee details»
Napa Therapeutics - VentureRadar
Napa Therapeutics is a pharmaceutical research organization dedicated to the discovery and โฆSee details»
New study results reinforce Tagrisso as the backbone therapy for โฆ
3 days ago New study results presented at the European Lung Cancer Congress (ELCC) โฆSee details»